Trial intelligence / Profile preview

HCQ in Mild COVID-19

NCT04491994Phase 3Completed

Sponsor
UNICEF
Start
Apr 2020
Primary completion
May 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of hydroxychloroquine in coronavirus disease 2019 (COVID-19), sponsored by UNICEF. Started Apr 2020; status: completed.

02

Drugs

hydroxychloroquine
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT04491994.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04491994.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call